Search Results - "PASTA, David J"

Endometriosis fertility index: the new, validated endometriosis staging system by Adamson, G. David, M.D, Pasta, David J., M.S

“…Objective To develop a clinical tool that predicts pregnancy rates (PRs) in patients with surgically documented endometriosis who attempt non-IVF conception…”
Get full text

Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study by Konstan, Michael W, Dr Prof, McKone, Edward F, MD, Moss, Richard B, Prof, Marigowda, Gautham, MD, Tian, Simon, MD, Waltz, David, MD, Huang, Xiaohong, PhD, Lubarsky, Barry, PhD, Rubin, Jaime, MPH, Millar, Stefanie J, MS, Pasta, David J, MS, Mayer-Hamblett, Nicole, PhD, Goss, Christopher H, Prof, Morgan, Wayne, Prof, Sawicki, Gregory S, MD

“…Summary Background The 24-week safety and efficacy of lumacaftor/ivacaftor combination therapy was shown in two randomised controlled trials (RCTs)—TRAFFIC and…”
Get full text

The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy by Cooperberg, Matthew R, Pasta, David J, Elkin, Eric P, Litwin, Mark S, Latini, David M, Du Chane, Janeen, Carroll, Peter R

“…Multivariate prognostic instruments aim to predict risk of recurrence among patients with localized prostate cancer. We devised a novel risk assessment tool…”
Get more information

Impact of socioeconomic status, race, and ethnicity on quality of life in patients with cystic fibrosis in the United States by Quittner, Alexandra L, Schechter, Michael S, Rasouliyan, Lawrence, Haselkorn, Tmirah, Pasta, David J, Wagener, Jeffrey S

“…Patient-reported outcomes are increasingly used in clinical trials to assess the natural history of chronic diseases and the efficacy of new treatments…”
Get more information

Risk Factors For Rate of Decline in Forced Expiratory Volume in One Second in Children and Adolescents with Cystic Fibrosis by Konstan, Michael W., MD, Morgan, Wayne J., MD, Butler, Steven M., PhD, Pasta, David J., MS, Craib, Marcia L., MS, Silva, Stefanie J., MS, Stokes, Dennis C., MD, Wohl, Mary Ellen B., MD, Wagener, Jeffrey S., MD, Regelmann, Warren E., MD, Johnson, Charles A., MBChB

“…Objectives To characterize the rate of decline of forced expiratory volume in 1 second (FEV1 ) in children and adolescents with cystic fibrosis and to identify…”
Get full text

Improvements in Lung Function and Height among Cohorts of 6-Year-Olds with Cystic Fibrosis from 1994 to 2012 by VanDevanter, Donald R., PhD, Pasta, David J., MS, Konstan, Michael W., MD

“…Objective To characterize spirometry and height changes in cohorts of 6-year-old children with cystic fibrosis (CF). Study design Global Lung Initiative forced…”
Get full text

Probability of Treatment Following Acute Decline in Lung Function in Children with Cystic Fibrosis is Related to Baseline Pulmonary Function by Morgan, Wayne J., MD, Wagener, Jeffrey S., MD, Yegin, Ashley, MD, Pasta, David J., MS, Millar, Stefanie J., MS, Konstan, Michael W., MD

“…Objective To determine whether the association between high forced expiratory volume in 1 second (FEV1 ) and increased rate of decline in FEV1 in children with…”
Get full text

Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy by Cooperberg, Matthew R., Freedland, Stephen J., Pasta, David J., Elkin, Eric P., Presti, Joseph C., Amling, Christopher L., Terris, Martha K., Aronson, William J., Kane, Christopher J., Carroll, Peter R.

“…BACKGROUND. The University of California, San Francisco (UCSF) Cancer of the Prostate Risk Assessment (CAPRA) is a novel preoperative index which predicts the…”
Get full text

Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry by Gray, Emma, Pasta, David J, Norris, Suzanne, O'Leary, Aisling

“…Observational studies are used to measure the effectiveness of an intervention in non-experimental, real world scenarios at the population level and are…”
Get full text

Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies by Benza, Raymond L, Gomberg-Maitland, Mardi, Elliott, C Greg, Farber, Harrison W, Foreman, Aimee J, Frost, Adaani E, McGoon, Michael D, Pasta, David J, Selej, Mona, Burger, Charles D, Frantz, Robert P

“…Pulmonary arterial hypertension is a progressive, fatal disease. Published treatment guidelines recommend treatment escalation on the basis of regular patient…”
Get full text

Relationship between Inhaled Corticosteroid Therapy and Rate of Lung Function Decline in Children with Cystic Fibrosis by Ren, Clement L., MD, Pasta, David J., MS, Rasouliyan, Lawrence, MPH, Wagener, Jeffrey S., MD, Konstan, Michael W., MD, Morgan, Wayne J., MD, CM

“…Objective To assess the relationship between inhaled corticosteroids (ICS) use and lung function decline in children with cystic fibrosis (CF) using the…”
Get full text

Impact of obesity on prostate cancer recurrence after radical prostatectomy: Data from CaPSURE by Bassett, William W., Cooperberg, Matthew R., Sadetsky, Natalia, Silva, Stefanie, DuChane, Janeen, Pasta, David J., Chan, June M., Anast, Jason W., Carroll, Peter R., Kane, Christopher J.

“…To determine the association between obesity and prostate cancer recurrence after primary treatment with radical prostatectomy. Data were abstracted from…”
Get full text

Socioeconomic Status and the Likelihood of Antibiotic Treatment for Signs and Symptoms of Pulmonary Exacerbation in Children with Cystic Fibrosis by Schechter, Michael S., MD, MPH, McColley, Susanna A., MD, Regelmann, Warren, MD, Millar, Stefanie J., MS, Pasta, David J., MS, Wagener, Jeffrey S., MD, Konstan, Michael W., MD, Morgan, Wayne J., MD

“…Objective To determine whether socioeconomic status (SES) influences the likelihood of antibiotic treatment of pulmonary exacerbations in patients with cystic…”
Get full text

Medical Expenditures and Earnings Losses Among US Adults With Arthritis in 2013 by Murphy, Louise B., Cisternas, Miriam G., Pasta, David J., Helmick, Charles G., Yelin, Edward H.

“…Objective We estimated the economic impact of arthritis using 2013 US Medical Expenditure Panel Survey (MEPS) data. Methods We calculated…”
Get full text

Alternative Methods for Defining Osteoarthritis and the Impact on Estimating Prevalence in a US Population‐Based Survey by Cisternas, Miriam G., Murphy, Louise, Sacks, Jeffrey J., Solomon, Daniel H., Pasta, David J., Helmick, Charles G.

“…Objective Provide a contemporary estimate of osteoarthritis (OA) by comparing the accuracy and prevalence of alternative definitions of OA. Methods The Medical…”
Get full text

Trends in Medical Care Expenditures of US Adults with Arthritis and Other Rheumatic Conditions 1997 to 2005 by CISTERNAS, Miriam G, MURPHY, Louise B, YELIN, Edward H, FOREMAN, Aimee J, PASTA, David J, HELMICK, Charles G

“…Objective. To examine trends in annual medical expenditures from 1997 to 2005 among adults with arthritis and other rheumatic conditions (denoted Arthritis…”
Get full text

Impact of pregnancy on women with cystic fibrosis by McMullen, Ann H, Pasta, David J, Frederick, Paul D, Konstan, Michael W, Morgan, Wayne J, Schechter, Michael S, Wagener, Jeffrey S

“…Improvements in the health and survival of patients with cystic fibrosis (CF) have led to increasingly normal lifestyles, including successful pregnancies in…”
Get more information

A framework for modelling fertility motivation in couples by Miller, Warren, Severy, Lawrence, Pasta, David

“…We present a theoretical framework that organizes individual-level fertility motivations into a couple-level model. One feature of this framework is the…”
Get full text

Sustained Benefit from ivacaftor demonstrated by combining clinical trial and cystic fibrosis patient registry data by Sawicki, Gregory S, McKone, Edward F, Pasta, David J, Millar, Stefanie J, Wagener, Jeffrey S, Johnson, Charles A, Konstan, Michael W

“…In clinical trials, patients with cystic fibrosis and a G551D mutation who received ivacaftor experienced improvements in pulmonary and nutritional outcomes…”
Get full text

Shifting patterns of inhaled antibiotic use in cystic fibrosis by Moskowitz, Samuel M., Silva, Stefanie J., Mayer‐Hamblett, Nicole, Pasta, David J., Mink, David R., Mabie, Jenny A., Konstan, Michael W., Wagener, Jeffrey S.

“…Rationale: Antibiotic inhalation has become widely accepted as a standard treatment for cystic fibrosis (CF) airway infection. We assessed the prevalence and…”
Get full text